On the nature of the urinary volume response to diuretic agents by patients with edema.
D000328:Adult; D000368:Aged; D002717:Chlormerodrin / Q000627:therapeutic use; D002740:Chlorothiazide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003685:Dehydrocholic Acid / Q000627:therapeutic use; D004231:Diuresis / Q000187:drug effects*; D004232:Diuretics / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D009941:Organomercury Compounds; D010640:Phenothiazines; D013148:Spironolactone; D002740:Chlorothiazide; D002717:Chlormerodrin; D003685:Dehydrocholic Acid; D011241:Prednisone; D006854:Hydrocortisone; D008775:Methylprednisolone